Expression of leukaemia inhibitory factor in skin of patients with amyotrophic lateral sclerosis

Lancet

Volumn 353, Issue 9170, 1999, Pages 2126-2127

  Hu, Jianguo ^a   Imai, Takashi ^a   Shimizu, Natsue ^a   Nakagawa, Hachiro ^a   Ono, Seiitsu ^a  

^a BML   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKEMIA INHIBITORY FACTOR;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE DURATION; DRUG TARGETING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN; SKIN BIOPSY;

EID: 0033584063     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)01520-2     Document Type: Article

References (5)

1. Furukawa T., Toyokura Y. Amyotrophic lateral sclerosis and bedsores. Lancet. i:1976;862.
2. Ono S., Nagao K., Yamauchi M. Amorphous material of skin in amyotrophic lateral sclerosis: a morphologic and biochemical study. Neurology. 44:1994;537-540.
3. Ono S., Imai T., Shimizu N., Nakagawa H., Hu J. Ciliary neutrophic fact or in skin biopsies of patients with amyotrophic lateral sclerosis. Lancet. 352:1998;958-959.
4. Meyer M.A., Potter N.T. Sporadic ALS and chromosome 22: evidence for a possible neurofilament gene defect. Muscle Nerve. 18:1995;536-539.
5. Kurek J.B., Radford A.J., Crump D.E.et al. (AM424) a promising growth factor for the treatment of ALS. J Neurol Sci. 160(suppl 1):1998;S106-S113.